Recent insider trends for TrovaGene, Inc. (NASDAQ:TROV) have caught the attention of investors. Patters in insider activity can help analysts formulate an outlook for a stock. In the case of TROV, the data has a lot to say about how the stock might perform going forward.
Institutions own 04.79% of TrovaGene, Inc. (TROV)’s shares. The total value of these holdings, in millions, is $1. Among active positions in the latest quarter, 10 holders increased their positions by a total of 101151 shares, 23 holders decreased the positions by a total of 2.83 million shares, and 18 holders held their positions. This works out to a net decrease in ownership of 2.72 million shares, and suggests that institutions are feeling bearish about the stock.
Among new and sold out positions, 2 holders initiated new positions by a total of 19070 shares and 8 holders exited their positions by a total of 2.41 million shares. This nets out to a decrease of 2.39 million shares and is another bearish sign for TROV.
In the last three months, insiders executed a total of 4 trades. 4 were sells. Insider ownership decreased by a total of 139985 shares, which suggests that TROV’s key executives are feeling less optimistic about the outlook for the stock. The data from the past twelve months tells a different story: insiders executed 1 buys and 6 sells, and ownership increased by a net of 584145 shares.
Short interest, or the number of a stock’s tradable shares currently being shorted, is another metric investors use to get a pulse on sentiment. TrovaGene, Inc. (NASDAQ:TROV)’s short interest is 4.13 million shares, or 11.19% of the float. This represents an increase of 4% in the number of shares being shorted compared to the previous reading, and implies that investors felt more pessimistic about the stock during the past two weeks.
In light of the insider ownership and trading data it makes sense to consider technicals to see if they come to a similar conclusion about the outlook for TROV. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that TROV is a Strong buy, which implies that TROV is expected to outperform the market based on prior trading patterns.
Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bearish. Technical indicators (also) suggest that TrovaGene, Inc. (NASDAQ:TROV) is undervalued.